Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications
Taroh Satoh, Philippe Barthélémy, Lucia Nogová, Kazunori Honda, Hidekazu Hirano, Keun-Wook Lee, Sun Young Rha, Min‐Hee Ryu, Joon Oh Park, Toshihiko Doi, Jaffer A. Ajani, Nanae Hangai, Jill D. Kremer, Mark Mina, Mei Liu, Kohei Shitara
Topics & Concepts
Gastroesophageal JunctionCancerMedicineInternal medicinePhase (matter)GastroenterologyOncologyAdenocarcinomaChemistryOrganic chemistryFibroblast Growth Factor ResearchEsophageal Cancer Research and TreatmentIgG4-Related and Inflammatory Diseases